New Targeted Therapies for RA: Unmet Needs in Primary Care

PROGRAM DESCRIPTION Rheumatoid arthritis (RA) is a chronic, painful, debilitating inflammatory joint disease that affects 1.5 million people in the United States and impacts activities of daily living in many ...

PROGRAM DESCRIPTION
Rheumatoid arthritis (RA) is a chronic, painful, debilitating inflammatory joint disease that affects 1.5 million people in the United States and impacts activities of daily living in many patients. If left untreated, or upon lack of response to treatment, RA is associated with disability, loss of productivity, lowered quality of life, and premature death. RA is also associated with several comorbid conditions such as cardiovascular disease, infection, mental health conditions, and malignancies. Increased hospitalizations and ambulatory visits are also attributed to RA, and patients with RA report significantly poorer quality of life. This disease imposes a significant healthcare burden both on the patient and the healthcare system.

EDUCATIONAL OBJECTIVES
Upon completion of this educational activity, participants should be able to:Implement routine screening in practice to improve the early and accurate diagnosis of RAApply guideline recommendations for treating to remission and preserving patient function in RAReview the underlying pathophysiology of RA and the role of emerging targeted therapies, including cytokine inhibition, for patients with RAImplement strategies that promote early identification of important comorbidities and their management in patients with RA

---

Write the first review

Resource tags